References
- Li Y, Ming M, Li C, et al. The emerging role of the hedgehog signaling pathway in immunity response and autoimmune diseases. Autoimmunity. 2023;56(1):1.
- Fugger L, Jensen LT, Rossjohn J. Challenges, progress, and prospects of developing therapies to treat autoimmune diseases. Cell. 2020;181(1):63–10.
- Rogers MAM, Wei MY, Kim C, et al. Sex differences in autoimmune multimorbidity in type 1 diabetes mellitus and the risk of cardiovascular and renal disease: a longitudinal study in the United States, 2001-2017. J Womens Health (Larchmt). 2020;29(4):511–519.
- Fraenkel L, Bathon JM, England BR, et al. 2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2021;73(7):924–939.
- Nakase H, Uchino M, Shinzaki S, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol. 2021;56(6):489–526.
- Lamberg T, Sipponen T, Valtanen S, et al. Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseases. Autoimmunity. 2022;55(5):275–284.
- Marinho A, Delgado Alves J, Fortuna J, et al. Biological therapy in systemic lupus erythematosus, antiphospholipid syndrome, and Sjögren’s syndrome: evidence- and practice-based guidance. Front Immunol. 2023;14:1117699.
- Atzeni F, Gianturco L, Talotta R, et al. Investigating the potential side effects of anti-TNF therapy for rheumatoid arthritis: cause for concern? Immunotherapy. 2015;7(4):353–361.
- Zheng J, Haberland V, Baird D, et al. Phenome-wide mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat Genet. 2020;52(10):1122–1131.
- Plenge RM, Scolnick EM, Altshuler D. Validating therapeutic targets through human genetics. Nat Rev Drug Discov. 2013;12(8):581–594.
- Nelson MR, Tipney H, Painter JL, et al. The support of human genetic evidence for approved drug indications. Nat Genet. 2015;47(8):856–860.
- Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318(19):1925–1926.
- Smith GD, Ebrahim S. Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1–22.
- Li Y, Li Q, Cao Z, et al. The causal association of polyunsaturated fatty acids with allergic disease: a two-sample mendelian randomization study. Front Nutr. 2022;9:962787.
- Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10(5):e1004383.
- Gu X, Dou M, Su W, et al. Identifying novel proteins underlying schizophrenia via integrating pQTLs of the plasma, CSF, and brain with GWAS summary data. BMC Med. 2022;20(1):474.
- Lin J, Zhou J, Xu Y. Potential drug targets for multiple sclerosis identified through mendelian randomization analysis. Brain. 2023;146(8):3364–3372.
- Kurilshikov A, Medina-Gomez C, Bacigalupe R, et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet. 2021;53(2):156–165.
- Hom G, Graham RR, Modrek B, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med. 2008;358(9):900–909.
- Cortes A, Hadler J, Pointon JP, et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet. 2013;45(7):730–738.
- Faraco J, Lin L, Kornum BR, et al. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet. 2013;9(2):e1003270.
- Okada Y, Wu D, Trynka G, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014;506(7488):376–381.
- Bentham J, Morris DL, Graham DSC, et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet. 2015;47(12):1457–1464.
- Burgess S, Thompson SG, CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in mendelian randomization studies. Int J Epidemiol. 2011;40(3):755–764.
- Qin C, Diaz-Gallo LM, Tang B, et al. Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample mendelian randomization study. Eur J Epidemiol. 2023;38(7):809–819.
- Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658–665.
- Wang Q, Jia S, Lu Q, et al. Systemic lupus erythematosus is associated with the risk of coeliac disease: a mendelian randomisation study. Autoimmunity. 2023;56(1):2250103.
- Kia DA, Zhang D, Guelfi S, et al. Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets. JAMA Neurol. 2021;78(4):464–472.
- Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13(11):e1007081.
- Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression. Int J Epidemiol. 2015;44(2):512–525.
- Kamat MA, Blackshaw JA, Young R, et al. PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics. 2019;35(22):4851–4853.
- Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(D1):D605–D612.
- Szklarczyk D, Kirsch R, Koutrouli M, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638–D646.
- Ren F, Jin Q, Liu T, et al. Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers. J Transl Med. 2023;21(1):646.
- Paine A, Ritchlin CT. Targeting the interleukin-23/17 axis in axial spondyloarthritis. Curr Opin Rheumatol. 2016;28(4):359–367.
- Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed crohn’s disease susceptibility loci. Nat Genet. 2010;42(12):1118–1125.
- Hamilton F, Mentzer AJ, Parks T, et al. Variation in ERAP2 has opposing effects on severe respiratory infection and autoimmune disease. Am J Hum Genet. 2023;110(4):691–702.
- Klunk J, Vilgalys TP, Demeure CE, et al. Evolution of immune genes is associated with the black death. Nature. 2022;611(7935):312–319.
- Wordsworth BP, Cohen CJ, Davidson C, et al. Perspectives on the genetic associations of ankylosing spondylitis. Front Immunol. 2021;12:603726.
- Maben Z, Arya R, Rane D, et al. Discovery of selective inhibitors of endoplasmic reticulum aminopeptidase 1. J Med Chem. 2020;63(1):103–121.
- Camberlein V, Fléau C, Sierocki P, et al. Discovery of the first selective nanomolar inhibitors of ERAP2 by kinetic target-guided synthesis. Angew Chem Int Ed Engl. 2022;61(39):e202203560.
- Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491(7422):119–124.
- Jin YR, Yoon JK. The R-spondin family of proteins: emerging regulators of WNT signaling. Int J Biochem Cell Biol. 2012;44(12):2278–2287.
- Kang E, Yousefi M, Gruenheid S. R-Spondins are expressed by the intestinal stroma and are differentially regulated during Citrobacter rodentium- and DSS-Induced colitis in mice. PLoS One. 2016;11(4):e0152859.
- Chartier C, Raval J, Axelrod F, et al. Therapeutic targeting of tumor-derived R-Spondin attenuates β-catenin signaling and tumorigenesis in multiple cancer types. Cancer Res. 2016;76(3):713–723.
- Tan L, Ouyang T, Li X, et al. Serum sirtuin-1 a potential marker in the diagnosis of rheumatoid arthritis. Autoimmunity. 2023;56(1):2181234.
- Abd-Allah AR, Ahmad SF, Alrashidi I, et al. Involvement of histamine 4 receptor in the pathogenesis and progression of rheumatoid arthritis. Int Immunol. 2014;26(6):325–340.
- Meyer A, Yan S, Golumba-Nagy V, et al. Kinase activity profiling reveals contribution of G-protein signaling modulator 2 deficiency to impaired regulatory T cell migration in rheumatoid arthritis. J Autoimmun. 2021;124:102726.
- Sun L, Fu J, Zhou Y. Metabolism controls the balance of Th17/T-regulatory cells. Front Immunol. 2017;8(:1632.
- Agarwal S, Kraus Z, Dement-Brown J, et al. Human Fc receptor-like 3 inhibits regulatory T cell function and binds secretory IgA. Cell Rep. 2020;30(5):1292–1299.e3.
- Krischer JP, Liu X, Vehik K, et al. Predicting islet cell autoimmunity and type 1 diabetes: an 8-year TEDDY study progress report. Diabetes Care. 2019;42(6):1051–1060.
- Qi R, Singh D, Kao CC. Proteolytic processing regulates toll-like receptor 3 stability and endosomal localization. J Biol Chem. 2012;287(39):32617–32629.
- Inshaw JRJ, Cutler AJ, Crouch DJM, et al. Genetic variants predisposing most strongly to type 1 diabetes diagnosed under age 7 years lie near candidate genes that function in the immune system and in pancreatic β-cells. Diabetes Care. 2020;43(1):169–177.
- Apaolaza PS, Balcacean D, Zapardiel-Gonzalo J, et al. Islet expression of type I interferon response sensors is associated with immune infiltration and viral infection in type 1 diabetes. Sci Adv. 2021;7(9):eabd6527.
- Wang M, Chen X, Tan P, et al. Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer. Cancer Cell. 2022;40(9):1044–1059.e8.